Підписатись
Полтавський державний медичний університет, Poltava State Medical University
Полтавський державний медичний університет, Poltava State Medical University
Poltava State Medical University
Підтверджена електронна адреса в pdmu.edu.ua - Домашня сторінка
Назва
Посилання
Посилання
Рік
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
62612013
Ezetimibe added to statin therapy after acute coronary syndromes
CP Cannon, MA Blazing, RP Giugliano, A McCagg, JA White, P Theroux, ...
New England Journal of Medicine 372 (25), 2387-2397, 2015
52692015
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ...
New England journal of medicine 369 (14), 1327-1335, 2013
32042013
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
15592018
Advancing the global public health agenda for NAFLD: a consensus statement
JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ...
Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022
6082022
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation …
J Bousquet, HJ Schünemann, A Togias, C Bachert, M Erhola, PW Hellings, ...
Journal of Allergy and Clinical Immunology 145 (1), 70-80. e3, 2020
5352020
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial
SJ Nicholls, JJP Kastelein, GG Schwartz, D Bash, RS Rosenson, ...
Jama 311 (3), 252-262, 2014
3662014
Effect of meropenem-vaborbactam vs piperacillin-tazobactam on clinical cure or improvement and microbial eradication in complicated urinary tract infection: the TANGO I …
KS Kaye, T Bhowmick, S Metallidis, SC Bleasdale, OS Sagan, V Stus, ...
Jama 319 (8), 788-799, 2018
3432018
MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation
J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, C Bachert, ...
Allergy 70 (11), 1372-1392, 2015
3182015
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy
P Emery, J Vencovský, A Sylwestrzak, P Leszczyński, W Porawska, ...
Annals of the rheumatic diseases 76 (1), 51-57, 2017
2912017
ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
J Bousquet, PW Hellings, I Agache, A Bedbrook, C Bachert, ...
Clinical and translational allergy 6 (1), 47, 2016
2482016
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
J Bousquet, HJ Schünemann, PW Hellings, S Arnavielhe, C Bachert, ...
Journal of Allergy and Clinical Immunology 138 (2), 367-374. e2, 2016
2352016
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia
TM File Jr, DE Low, PB Eckburg, GH Talbot, HD Friedland, J Lee, ...
Journal of antimicrobial chemotherapy 66 (suppl_3), iii19-iii32, 2011
2272011
The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?
JV Lazarus, HE Mark, M Villota-Rivas, A Palayew, P Carrieri, M Colombo, ...
Journal of hepatology 76 (4), 771-780, 2022
2262022
2019 ARIA Care pathways for allergen immunotherapy
J Bousquet, O Pfaar, A Togias, HJ Schünemann, I Ansotegui, ...
Allergy 74 (11), 2087-2102, 2019
2232019
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo …
DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ...
The Lancet 394 (10204), 1169-1180, 2019
2222019
FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia
DE Low, TM File Jr, PB Eckburg, GH Talbot, H David Friedland, J Lee, ...
Journal of antimicrobial chemotherapy 66 (suppl_3), iii33-iii44, 2011
2212011
Stress relaxation in crystals
VI Dotsenko
physica status solidi (b) 93 (1), 11-43, 1979
2141979
Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells
G Volgareva, L Zavalishina, Y Andreeva, G Frank, E Krutikova, ...
BMC cancer 4, 1-10, 2004
2112004
Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement
J Bousquet, CA Akdis, M Jutel, C Bachert, L Klimek, I Agache, ...
Allergy 75 (10), 2440-2444, 2020
2062020
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20